PubRank

Akiko Maeda

Author PubWeight™ 52.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Essential role of Ca2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat Neurosci 2004 2.62
2 Rhodopsin signaling and organization in heterozygote rhodopsin knockout mice. J Biol Chem 2004 1.64
3 Delayed dark adaptation in 11-cis-retinol dehydrogenase-deficient mice: a role of RDH11 in visual processes in vivo. J Biol Chem 2005 1.58
4 Mechanism of all-trans-retinal toxicity with implications for stargardt disease and age-related macular degeneration. J Biol Chem 2011 1.55
5 Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina. J Biol Chem 2008 1.51
6 An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin Cancer Res 2002 1.45
7 Key enzymes of the retinoid (visual) cycle in vertebrate retina. Biochim Biophys Acta 2011 1.28
8 Photoreceptor proteins initiate microglial activation via Toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal. J Biol Chem 2013 1.22
9 Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 2011 1.18
10 Noninvasive multiphoton fluorescence microscopy resolves retinol and retinal condensation products in mouse eyes. Nat Med 2010 1.18
11 Loss of cone photoreceptors caused by chromophore depletion is partially prevented by the artificial chromophore pro-drug, 9-cis-retinyl acetate. Hum Mol Genet 2009 1.17
12 Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma. J Immunol 2002 1.14
13 Importance of membrane structural integrity for RPE65 retinoid isomerization activity. J Biol Chem 2010 1.12
14 Autophagy protects the retina from light-induced degeneration. J Biol Chem 2013 1.10
15 Novel RDH12 mutations associated with Leber congenital amaurosis and cone-rod dystrophy: biochemical and clinical evaluations. Vision Res 2007 1.08
16 Toll-like receptor 3 is required for development of retinopathy caused by impaired all-trans-retinal clearance in mice. J Biol Chem 2011 1.08
17 Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. J Clin Invest 2013 1.06
18 Retinyl ester homeostasis in the adipose differentiation-related protein-deficient retina. J Biol Chem 2008 1.04
19 Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season. J Clin Microbiol 2004 0.98
20 Kinetic, energetic, and mechanical differences between dark-state rhodopsin and opsin. Structure 2013 0.95
21 Retinal photodamage mediated by all-trans-retinal. Photochem Photobiol 2012 0.93
22 Modulation of molecular interactions and function by rhodopsin palmitylation. Biochemistry 2009 0.93
23 CCL3 production by microglial cells modulates disease severity in murine models of retinal degeneration. J Immunol 2014 0.92
24 Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice. Invest Ophthalmol Vis Sci 2009 0.91
25 Retinal pigmented epithelial cells obtained from human induced pluripotent stem cells possess functional visual cycle enzymes in vitro and in vivo. J Biol Chem 2013 0.91
26 Evaluation of potential therapies for a mouse model of human age-related macular degeneration caused by delayed all-trans-retinal clearance. Invest Ophthalmol Vis Sci 2009 0.90
27 Retinal cone and rod photoreceptor cells exhibit differential susceptibility to light-induced damage. J Neurochem 2012 0.87
28 Effects of long-term administration of 9-cis-retinyl acetate on visual function in mice. Invest Ophthalmol Vis Sci 2008 0.86
29 Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan--with special reference to minimizing outcome misclassification. Vaccine 2009 0.86
30 Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine. Vaccine 2006 0.85
31 Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity. Geriatr Gerontol Int 2008 0.84
32 Combined administration of (L)-cystine and (L)-theanine enhances immune functions and protects against influenza virus infection in aged mice. J Vet Med Sci 2009 0.83
33 Effectiveness of an influenza A (H1N1) 2009 monovalent vaccine among Japanese pregnant women: a prospective observational study assessing antibody efficacy. Vaccine 2012 0.82
34 Natural history of medium-sized atrial septal defect in pediatric cases. J Cardiol 2012 0.81
35 Immunogenicity and reactogenicity of a monovalent inactivated 2009 influenza A vaccine in adolescents: with special reference to pre-existing antibody. J Pediatr 2011 0.80
36 Multifunctional PEG retinylamine conjugate provides prolonged protection against retinal degeneration in mice. Biomacromolecules 2014 0.80
37 Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan. Vaccine 2010 0.80
38 Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season. Vaccine 2005 0.79
39 Molecular biology and analytical chemistry methods used to probe the retinoid cycle. Methods Mol Biol 2010 0.79
40 Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan. Vaccine 2005 0.79
41 Influenza vaccine effectiveness and confounding factors among young children. Vaccine 2008 0.79
42 Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines. Biochem Biophys Res Commun 2003 0.79
43 Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C. Influenza Other Respir Viruses 2012 0.79
44 Synthesis and evaluation of a nanoglobular dendrimer 5-aminosalicylic Acid conjugate with a hydrolyzable schiff base spacer for treating retinal degeneration. ACS Nano 2013 0.79
45 Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents. Vaccine 2008 0.79
46 Feasibility evaluation of a remote monitoring system for implantable cardiac devices in Japan. Int Heart J 2011 0.79
47 [Immunogenicity of trivalent-inactivated influenza vaccine among children less than 4 years old]. Kansenshogaku Zasshi 2007 0.78
48 Rapid deterioration of primary fourth ventricular outlet obstruction resulting in syndrome of inappropriate antidiuretic hormone secretion. Pediatr Int 2014 0.78
49 Essential tools for assessing influenza vaccine efficacy in improperly conducted studies: a Japanese perspective. Vaccine 2008 0.78
50 Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-A24-recoverin tetramer. Cancer Immunol Immunother 2002 0.76
51 Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons. Hum Vaccin Immunother 2015 0.75
52 Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients. Liver Int 2013 0.75
53 Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study. Hum Vaccin Immunother 2015 0.75
54 Detection of influenza vaccine effectiveness among nursery school children: Lesson from a season with cocirculating respiratory syncytial virus. Hum Vaccin Immunother 2015 0.75
55 Safety of a Pandemic Influenza Vaccine and the Immune Response in Patients with Duchenne Muscular Dystrophy. Intern Med 2015 0.75
56 Lactobacillus casei cell wall extract directly stimulates the expression of COX2 independent of Toll-like receptor 2 in rat glial cells. J Microbiol Immunol Infect 2012 0.75
57 [Literature review on the association between inactivated influenza vaccines and the Guillain-Barré syndrome]. Nihon Koshu Eisei Zasshi 2010 0.75
58 [Target groups for influenza vaccination]. Nihon Koshu Eisei Zasshi 2007 0.75
59 Supplementation with vitamin a derivatives to rescue vision in animal models of degenerative retinal diseases. Methods Mol Biol 2015 0.75
60 [Cross-induction of HI antibody against A (H3N2) of influenza HA vaccine]. Kansenshogaku Zasshi 2005 0.75
61 [Retinal degeneration diseases and the retinoid cycle]. Nippon Ganka Gakkai Zasshi 2009 0.75